Key Executives
| Name | Title | Pay | Exercised | Year Born |
|---|---|---|---|---|
| Mr. Simon Michel | CEO & Member of the Board | 992k | -- | 1977 |
| Mr. Samuel Kunzli | Chief Financial Officer | -- | -- | 1984 |
| Mr. Frank Mengis | Chief Operating Officer | -- | -- | 1964 |
| Mr. Thomas Kutt | Head of Investor Relations | -- | -- | -- |
| Dr. Nicolas Meyer | Chief Legal Officer & Secretary | -- | -- | 1971 |
| Mr. Michael Zaugg | Chief Corporate Officer | -- | -- | 1972 |
| Ms. Ulrike Bauer | Chief Business Officer of Ypsomed Delivery Systems | -- | -- | 1969 |
| Mr. Sebastien Delarive | Chief Business Officer of Ypsomed Diabetes Care | -- | -- | 1969 |
Ypsomed Holding AG
- Full Time Employees:
- 2,600
Description
Ypsomed Holding AG, together with its subsidiaries, develops, manufactures, and sells injection and infusion systems for pharmaceutical and biotechnology companies. The company operates through two segments, Ypsomed Delivery Systems and Ypsomed Diabetes Care. The Ypsomed Delivery Systems segment provides various injection systems, such as pen injectors, auto injectors, and wearable injectors, as well as other smart devices. This segment offers its products under the YDS brand. The Ypsomed Diabetes Care segment sells and trades in insulin pumps, infusion sets, pen needles, blood glucose monitoring systems, accessories, and other day-to-day items for diabetics. This segment offers its products under the mylife brand name. The company offers precision turned parts; and contract manufacturing and other services. It markets its products through pharmaceutical partners, as well as through its own distribution network and independent distributors. It operates in Switzerland, Europe, North America, and internationally. Ypsomed Holding AG was founded in 1984 and is headquartered in Burgdorf, Switzerland.
Corporate Governance
Upcoming Events
May 21, 2025 at 10:59 AM UTC
Ypsomed Holding AG Earnings Date
Recent Events
Recent Events Information Not Available